Drug Target Review2024-03-07T12:00:20
Researchers have developed an algorithm which could improve diagnostics of ovarian high-grade serous carcinoma.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-08-03T06:00:00
Author Dr Xiaoxiao Wang, Yan Zhang and Junli Zhao
2026-03-11T14:00:00
Sponsored by Merck
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2026-05-26T09:05:00
Contributor Thomas Clozel M.D., Drug Target Review
2026-07-21T09:36:00
Contributor Jayson Uffens, Drug Target Review
2023-03-20T13:41:33
Sponsored by Bio-Techne
Site powered by Webvision Cloud